Can sedation be used for equine lameness investigation?
PICO question In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness? Clinical bottom line Category of research question Diagnosis...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
RCVS Knowledge
2021-06-01
|
Series: | Veterinary Evidence |
Subjects: | |
Online Access: | https://veterinaryevidence.org/index.php/ve/article/view/373 |
id |
doaj-916d317e397e4edb948fb601ebe9d37c |
---|---|
record_format |
Article |
spelling |
doaj-916d317e397e4edb948fb601ebe9d37c2021-10-05T10:41:06ZengRCVS KnowledgeVeterinary Evidence2396-97762021-06-016210.18849/ve.v6i2.373373Can sedation be used for equine lameness investigation?Helene Termansen0Lucinda Meehan1Langford Veterinary ServicesUniversity of BristolPICO question In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness? Clinical bottom line Category of research question Diagnosis The number and type of study designs reviewed Six papers were critically reviewed. There were two crossover clinical studies, three crossover controlled clinical studies and a randomised controlled clinical study Strength of evidence Moderate Outcomes reported There was limited evidence to suggest that xylazine and romifidine in combination with butorphanol has an effect on forelimb lameness and that detomidine has an effect on hindlimb lameness. Most evidence suggests that xylazine alone or in combination with butorphanol has no effect on the lameness Conclusion In general, sedating a horse with an a2-adrenergic agonist alone or in combination with butorphanol tartrate does not change the baseline degree of lameness. Due to the large variation in the measurements, the small magnitude of few significant effects and the inconsistency of these significant findings, there is insufficient evidence to recommend avoiding the use of sedation in cases where it would increase the safety of those involved. However, regardless of protocol used, clinicians must appreciate the possibility of individual horse variation How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.https://veterinaryevidence.org/index.php/ve/article/view/373horsesequinesedationsedativetranquiliserlamenessgait |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Helene Termansen Lucinda Meehan |
spellingShingle |
Helene Termansen Lucinda Meehan Can sedation be used for equine lameness investigation? Veterinary Evidence horses equine sedation sedative tranquiliser lameness gait |
author_facet |
Helene Termansen Lucinda Meehan |
author_sort |
Helene Termansen |
title |
Can sedation be used for equine lameness investigation? |
title_short |
Can sedation be used for equine lameness investigation? |
title_full |
Can sedation be used for equine lameness investigation? |
title_fullStr |
Can sedation be used for equine lameness investigation? |
title_full_unstemmed |
Can sedation be used for equine lameness investigation? |
title_sort |
can sedation be used for equine lameness investigation? |
publisher |
RCVS Knowledge |
series |
Veterinary Evidence |
issn |
2396-9776 |
publishDate |
2021-06-01 |
description |
PICO question
In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness?
Clinical bottom line
Category of research question
Diagnosis
The number and type of study designs reviewed
Six papers were critically reviewed. There were two crossover clinical studies, three crossover controlled clinical studies and a randomised controlled clinical study
Strength of evidence
Moderate
Outcomes reported
There was limited evidence to suggest that xylazine and romifidine in combination with butorphanol has an effect on forelimb lameness and that detomidine has an effect on hindlimb lameness.
Most evidence suggests that xylazine alone or in combination with butorphanol has no effect on the lameness
Conclusion
In general, sedating a horse with an a2-adrenergic agonist alone or in combination with butorphanol tartrate does not change the baseline degree of lameness. Due to the large variation in the measurements, the small magnitude of few significant effects and the inconsistency of these significant findings, there is insufficient evidence to recommend avoiding the use of sedation in cases where it would increase the safety of those involved. However, regardless of protocol used, clinicians must appreciate the possibility of individual horse variation
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care. |
topic |
horses equine sedation sedative tranquiliser lameness gait |
url |
https://veterinaryevidence.org/index.php/ve/article/view/373 |
work_keys_str_mv |
AT helenetermansen cansedationbeusedforequinelamenessinvestigation AT lucindameehan cansedationbeusedforequinelamenessinvestigation |
_version_ |
1716843284102381568 |